Lv1
50 积分 2025-06-27 加入
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)
3个月前
已完结
Is neoadjuvant therapy necessary for resectable pancreatic cancer? A review of randomized controlled trials to date: a narrative review
3个月前
已关闭
Toward an individualized strategy in perioperative chemotherapy for pancreatic cancer
3个月前
已关闭
Perioperative Chemotherapy and Total Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma
3个月前
已关闭
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial
3个月前
已完结
SMYD3 Activates Fatty Acid β-Oxidation to Promote Self-Renewal of Leukemia Stem Cells
6个月前
已完结
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer
8个月前
已完结
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9–Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment
8个月前
已关闭
Pancreatic cancer
8个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
10个月前
已完结
皖公网安备34019202002308
